Revenue | ₹1,783.83Cr |
Net Profits | ₹156.89Cr |
Net Profit Margins | 8.80% |
Alembic Pharmaceuticals Ltd’s revenue jumped 17.31% since last year same period to ₹1,783.83Cr in the Q4 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 4.77% jump in its revenue since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit fell -11.96% since last year same period to ₹156.89Cr in the Q4 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 13.34% jump in its net profits since last 3-months.
Alembic Pharmaceuticals Ltd’s net profit margin fell -24.96% since last year same period to 8.80% in the Q4 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 8.18% jump in its net profit margins since last 3-months.
The revenue for Alembic Pharmaceuticals Ltd in the Q4 results 2024 was ₹1,783.83Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q4 results 2024 was ₹156.89Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q4 results 2024 was 8.80%.
The revenue for Alembic Pharmaceuticals Ltd in the Q4 results 2023 was ₹1,520.58Cr.
The net profit for Alembic Pharmaceuticals Ltd in the Q4 results 2023 was ₹178.21Cr.
The net profit margin for Alembic Pharmaceuticals Ltd in the Q4 results 2023 was 11.72%.